VSee Health, Inc. Earnings Per Share (Basic)
VSee Health, Inc. (VSEE) reported Earnings Per Share (Basic) of -$0.05 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-05-15
- VSee Health, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.03.
- VSee Health, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.05.
- VSee Health, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.25.
- VSee Health, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.02.
- VSee Health, Inc. earnings per share, basic for fiscal 2025 was -$0.73.
- VSee Health, Inc. earnings per share, basic for fiscal 2024 was -$5.65.
- VSee Health, Inc. earnings per share, basic for fiscal 2023 was -$0.38.
- VSee Health, Inc. earnings per share, basic for fiscal 2022 was -$0.25.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.03 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$0.05 10-Q · filed 2026-05-15 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.73 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$0.02 10-Q · filed 2025-11-14 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.42 10-Q · filed 2025-11-14 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$0.16 10-Q/A · filed 2025-11-20 | -$0.40 10-Q/A · filed 2025-11-20 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$4.01 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-03-31 | -$0.24 10-Q · filed 2026-05-15 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$3.88 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$4.70 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||||
| 2024-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$3.70 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$4.79 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$5.65 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$3.58 10-Q · filed 2025-11-14 | -$3.43 10-Q · filed 2024-11-14 | -$5.35 derived: net income ÷ weighted average shares · filed 2025-11-20 | -$6.53 10-Q · filed 2025-11-14 | -$6.24 10-Q · filed 2024-11-14 | -$6.51 derived: net income ÷ weighted average shares · filed 2025-11-20 | ||
| 2024-06-30 | -$0.12 10-Q/A · filed 2025-11-20 | -$0.06 10-Q · filed 2024-09-23 | -$0.11 10-Q/A · filed 2025-11-20 | -$0.07 10-Q · filed 2024-09-23 | -$0.47 derived: net income ÷ weighted average shares · filed 2025-11-20 | -$0.44 derived: net income ÷ weighted average shares · filed 2025-11-20 | ||
| 2024-03-31 | $0.01 10-Q · filed 2025-10-15 | -$0.27 10-Q · filed 2024-05-15 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-10-15 | -$0.32 derived: net income ÷ weighted average shares · filed 2025-10-15 | -$0.43 derived: net income ÷ weighted average shares · filed 2025-10-15 | |||
| 2023-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2025-08-29 | -$0.27 derived: net income ÷ weighted average shares · filed 2025-08-29 | -$0.39 derived: net income ÷ weighted average shares · filed 2025-08-29 | -$0.38 10-K/A · filed 2025-08-29 | -$1.08 10-K · filed 2024-04-12 | |||
| 2023-09-30 | -$0.02 10-K/A · filed 2025-08-29 | $0.02 10-Q · filed 2023-11-20 | -$0.09 derived: net income ÷ weighted average shares · filed 2025-08-29 | -$0.12 10-K/A · filed 2025-08-29 | -$0.37 10-Q · filed 2023-11-20 | -$0.39 derived: net income ÷ weighted average shares · filed 2025-08-29 | ||
| 2023-06-30 | -$0.11 10-K/A · filed 2025-08-29 | $0.06 10-Q · filed 2023-08-21 | -$0.22 10-K/A · filed 2025-08-29 | -$0.39 10-Q · filed 2023-08-21 | -$0.45 derived: net income ÷ weighted average shares · filed 2025-08-29 | -$0.41 derived: net income ÷ weighted average shares · filed 2025-08-29 | ||
| 2023-03-31 | -$0.05 10-K/A · filed 2025-08-29 | -$0.45 10-Q · filed 2023-05-15 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-08-29 | -$0.31 derived: net income ÷ weighted average shares · filed 2025-08-29 | -$0.32 derived: net income ÷ weighted average shares · filed 2025-08-29 | |||
| 2022-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-04-12 | -$0.19 derived: net income ÷ weighted average shares · filed 2024-04-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-04-12 | -$0.25 10-K · filed 2024-04-12 | ||||
| 2022-09-30 | -$0.05 10-Q · filed 2023-11-20 | -$0.10 derived: net income ÷ weighted average shares · filed 2023-11-20 | -$0.13 10-Q · filed 2023-11-20 | |||||
| 2022-06-30 | -$0.04 10-Q · filed 2023-08-21 | -$0.08 10-Q · filed 2023-08-21 | ||||||
| 2022-03-31 | -$0.04 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | -$0.07 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |